Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA

Stroke

Volumn 29, Issue 2, 1998, Pages 462-466

  Kostulas, Nikolaos ^a   Kivisäkk, Pia ^a   Huang, Yumin ^a   Matusevicius, Darius ^a   Kostulas, Vasilios ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebral ischemia; Chemokines; Interleukins

Indexed keywords

INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0344972923     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.2.462     Document Type: Article

References (27)

1. Zhang RL, Chopp M, Chen H, Garcia JH. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2h) middle cerebral artery occlusion in the rat. J Neurol Sci. 1994;125:3-10.
2. Härtl R, Schürer L, Schmid-Schönbein GW, del Zoppo GJ. Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:1108-1119.
3. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, Jones ML, Miyasaka M, Ward PA. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology. 1994;44: 1747-1751.
4. Chopp M. Anti-adhesion molecule antibody reduces ischemic cell damage after transient MCAO in the rat. J Cereb Blood Flow Metab. 1995;15(suppl 1):S57. Abstract.
5. Pozilli C, Lenzi GL, Argentino C, Carolei A, Rasura M, Signore A, Bozzao L, Pozilli P. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke. 1985;16:251-255.
6. Wang P, Kao C, Mui M, Wang S. Leukocyte infiltration in acute hemispheric ischemic stroke. Stroke. 1993;24:236-240.
7. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci. 1996;137:69-78.
8. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994;122:135-139.
9. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995; 37:800-805.
10. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet. 1997;349:490-495.
11. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993;365:654-657.
12. Yamasaki Y, Matsuo Y, Matsuura N, Onodera H, Itoyama Y, Kogure K. Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke. 1995;26:318-322.
13. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
14. Link J. Interferon-γ, interleukin-4 and transforming growth factor-β mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol Scand. 1994;90(suppl):1-58.
15. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
16. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating tactor by monomeric interleukin-8. Am J Pathol. 1989;134:755-760.
17. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991;254: 99-102.
18. Leonard JE, Yoshimura T, Tanaka S, Raffeld M. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol. 1991;96:690-694.
19. Swensson O, Schubert C, Christophers E, Schröder JM. Inflammatory properties of neutrophil-activating protein-1/interleukin-8 (NAP-1/IL-8) in human skin: a light- and electromicroscopic study. J Invest Dermatol. 1991;96:682-689.
20. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988;167: 1547-1559.
21. Masure S, Proost P, van Damme J, Opdenakker G. Purification and identification of 91-kDa neutrophil gelatinase-release by the activating peptide interleukin-8. Eur J Biochem. 1991;198:391-398.
22. Baggiolini M, Imboden P, Derniers PA. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide-1 (IL-8/NAP-1). Cytokines. 1992;4:1-17.
23. Detmers P, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein-1/interleukin-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990;171:1155-1162.
24. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
25. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1β. Science. 1989;243:1467-1469.
26. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol. 1995;147:1477-1486.
27. Garcia J, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol. 1994;144:188-199.